Unfavorable treatment outcomes among patients with drugresistant TB in Uganda
![Thumbnail](/xmlui/bitstream/handle/123456789/2895/Unfavorable%20treatment%20outcomes%20among%20patients%20with%20drug%20resistant%20TB%20in%20Uganda.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Date
2023Author
Kintu, T. M.
Mwanahamisi, B. S.
Muwanguzi, M.
Kyagambiddwa, T.
Miiro, E.
Tishekwa, N.
Lodiong, L. J. D.
Timbiine, A. K.
Tumukunde, P.
Baluku, J. B.
Nuwagira, E.
Metadata
Show full item recordAbstract
Background: Drug-resistant TB (DR-TB) remains a significant public health burden and a threat to the progress made in TB control and prevention in sub- Saharan Africa.
Objective: To determine the risk-predictors of poor treatment outcomes in patients with DR-TB in Uganda.
Methods: We retrospectively reviewed medical records of adult Ugandans who had been treated for DR-TB at Mbarara Regional Referral Hospital (MRRH) in Uganda.
Results: Of the 385 files reviewed, 332 (86.2%) met the study inclusion criteria. Of these, 226 (68.1%) were men and 193 (58.1%) were HIV-positive. A total of 73 participants (22.7%) had unfavorable treatment outcomes (treatment failure, loss to follow-up or death). History of cigarette smoking (OR 5.10, 95% CI 2.4– 11.4; P, 0.001), age .60 years (OR 6.32, 95% CI 2.2–18.6; P, 0.001), anemia (OR 2.38, 95% CI 1.1–5.3; P ¼ 0.02) and thrombocytopenia (OR 3.60, 95% CI 1.6– 8.1; P, 0.001) were independent predictors of unfavorable treatment outcomes.
Conclusion: There is a high prevalence of unfavorable treatment outcomes among patients with DR-TB. Further research is required to design a prognostic model for DR-TB patients in a resource-limited setting.
Collections
- Research Articles [246]